Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Nutrition. 2022 Apr;96:111586. doi: 10.1016/j.nut.2021.111586. Epub 2022 Jan 4.
The aim of this study was to compare the predictive ability of the norepinephrine dose (NE), norepinephrine equivalent dose (NEQ), and mean arterial pressure (MAP)/NEQ index to predict the optimal time to initiate enteral nutrition in patients with shock on vasopressors.
We prospectively enrolled patients with shock who were receiving vasopressors and followed them for ≤28 d after enrollment. Patients who developed feeding intolerance (FI) during the follow-up period were allocated to the FI group and the remaining patients were allocated to the non-feeding intolerance (non-FI) group. The primary outcome was FI occurrence. The receiving operating characteristic curve (ROC) was used to evaluate the thresholds and predictive ability of NE, NEQ, and the MAP/NEQ index to predict FI.
Of the 66 patients enrolled, 47 developed FI. The MAP/NEQ index showed good predictive ability 6 h before EN initiation. The threshold of the MAP/NEQ index for predicting FI was 417 mmHg·μg·kg·min (specificity: 52.9%, sensitivity: 81%) with an area under the ROC curve (AUC) of 70.3% (95% confidence interval [CI], 55.1-85.5; P = 0.015). The threshold for the NE was 0.2 μg·kg/min (specificity: 47.1%, sensitivity: 88.1%), with an AUC of 65.3% (95% CI, 48.2-82.5; P = 0.067), and that for the NEQ was 0.2 μg·kg/min (specificity: 47.1%, sensitivity: 88.1%), with an AUC of 66.2% (95% CI, 49.3-83; P = 0.053).
Compared with the NE and NEQ, it could be possible with the MAP/NEQ index to distinguish earlier whether patients with shock receiving vasopressors were suitable for initiation of EN, thereby avoiding FI.
本研究旨在比较去甲肾上腺素剂量(NE)、去甲肾上腺素当量(NEQ)和平均动脉压(MAP)/NEQ 指数预测接受升压药物治疗的休克患者开始肠内营养的最佳时间的能力。
我们前瞻性地招募了正在接受升压药物治疗的休克患者,并在入组后随访≤28 天。在随访期间发生喂养不耐受(FI)的患者被分配到 FI 组,其余患者被分配到非喂养不耐受(非-FI)组。主要结局是 FI 的发生。采用接受者操作特征曲线(ROC)评估 NE、NEQ 和 MAP/NEQ 指数预测 FI 的阈值和预测能力。
在 66 名入组患者中,有 47 名患者发生 FI。MAP/NEQ 指数在开始肠内营养前 6 小时具有良好的预测能力。预测 FI 的 MAP/NEQ 指数的阈值为 417mmHg·μg·kg·min(特异性:52.9%,敏感性:81%),ROC 曲线下面积(AUC)为 70.3%(95%置信区间 [CI]:55.1-85.5;P=0.015)。NE 的阈值为 0.2μg·kg/min(特异性:47.1%,敏感性:88.1%),AUC 为 65.3%(95%CI:48.2-82.5;P=0.067),NEQ 的阈值为 0.2μg·kg/min(特异性:47.1%,敏感性:88.1%),AUC 为 66.2%(95%CI:49.3-83;P=0.053)。
与 NE 和 NEQ 相比,MAP/NEQ 指数可能更早地区分接受升压药物治疗的休克患者是否适合开始肠内营养,从而避免 FI 的发生。